OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The E484K Substitution in a SARS-CoV-2 Spike Protein Subunit Vaccine Resulted in Limited Cross-Reactive Neutralizing Antibody Responses in Mice
Longbo Hu, Yuhua Xu, Liping Wu, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 854-854
Open Access | Times Cited: 10
Longbo Hu, Yuhua Xu, Liping Wu, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 854-854
Open Access | Times Cited: 10
Showing 10 citing articles:
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 14
Niloofar Faraji, Tahereh Zeinali, Farahnaz Joukar, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30208-e30208
Open Access | Times Cited: 14
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 10
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 10
Preparation and immunological activity evaluation of an intranasal protein subunit vaccine against ancestral and mutant SARS-CoV-2 with curdlan sulfate/O-linked quaternized chitosan nanoparticles as carrier and adjuvant
Yipan Chen, Yan Wang, Zu‐Yi Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133733-133733
Closed Access | Times Cited: 2
Yipan Chen, Yan Wang, Zu‐Yi Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133733-133733
Closed Access | Times Cited: 2
Protective role of vitamin D status against COVID-19: a mini-review
Maryam Vasheghani, Mahsa Rekabi, Makan Sadr
Endocrine (2022) Vol. 79, Iss. 2, pp. 235-242
Open Access | Times Cited: 6
Maryam Vasheghani, Mahsa Rekabi, Makan Sadr
Endocrine (2022) Vol. 79, Iss. 2, pp. 235-242
Open Access | Times Cited: 6
A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly
Longbo Hu, Yongjie Tang, Lingling Mei, et al.
Antiviral Research (2022) Vol. 209, pp. 105509-105509
Open Access | Times Cited: 6
Longbo Hu, Yongjie Tang, Lingling Mei, et al.
Antiviral Research (2022) Vol. 209, pp. 105509-105509
Open Access | Times Cited: 6
A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
Longbo Hu, Jiajing Jiang, Yongjie Tang, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1548-1548
Open Access | Times Cited: 3
Longbo Hu, Jiajing Jiang, Yongjie Tang, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1548-1548
Open Access | Times Cited: 3
Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice
Huijie Yang, Ying Xie, Shuyan Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Huijie Yang, Ying Xie, Shuyan Li, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine
Ria Lassaunière, Charlotta Polacek, Jeanette Linnea Tingstedt, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6505-6513
Closed Access | Times Cited: 1
Ria Lassaunière, Charlotta Polacek, Jeanette Linnea Tingstedt, et al.
Vaccine (2023) Vol. 41, Iss. 43, pp. 6505-6513
Closed Access | Times Cited: 1
Omicron variant of COVID-19: A focused review of biologic, clinical, and epidemiological changes
Hossein Majlesi, Saba Shahsavan, Yeganeh Farsi, et al.
Immunopathologia Persa (2022)
Open Access
Hossein Majlesi, Saba Shahsavan, Yeganeh Farsi, et al.
Immunopathologia Persa (2022)
Open Access
